Less than 14 months after becoming a standalone company, Johnson & Johnson’s consumer healthcare spinout Kenvue is staring down an activist investor.
The investor, Starboard …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.